Long-Term Effects of COVID-19 on Cardiopulmonary Health.
Main Article Content
Abstract
Background: COVID-19 has strained the health of the global population, with post-viral squeal being witnessed in many of the patients who survive the illness. Chief among them is cardiology, where myocarditis and reduced lung capacity has been reported systemically. Knowledge of these long-term consequences is important to help direct recovery processes and gain better results in impacted patients.
Objectives: To employ a cross-sectional design to evaluate cardiopulmonary consequences caused by COVID-19, with cardiovascular and pulmonary functions dysfunction after the first 6-month post-recovery among patients.
Study design: A cross sectional study.
Palace and duration of study. Department of pulmonology Gkmc swabi form jan 2024 to july 2024
Methods: A cross sectional study was carried out using 120 COVID-19 survivors. Specific cardiac and pulmonary function tests included echocardiography, spirometry for lung function tests and for the exercise stress test for functional capacity. The conducted study incorporated heart rate, ejection fraction, and lung capacity measurements with the participants. Statistical analysis was done in SPSS statistically significant P value was 0.05, and results have been displayed in mean standard deviation.
Results: Of the 120 patients (mean age 48.3 ± 11.2years) twenty of the patients had reduced ejection fraction less than 50% and forty percent had restrictive lung disease on spirometry. The mean ejection fraction was 55,6% ± 7,8% and the mean forced vital capacity (FVC) were 70% ± 8,6 of predicted values. P < 0.05 for differences in lung capacity between the affected and unaffected groups was also obtained, where the p-value was less than 0.01. Pulmonary lesions were more frequent in severe initial groups of illness.
Conclusions: COVID-19 survivors showed moderate to severe prolonged impairment of cardiopulmonary function in this study. The follow-up care means that different assessments of cardiovascular and pulmonary systems should be made to manage and use for patient’s benefit.